N01DA-22-8959 Amendment No. 01.pdf

PDF 682 KB Posted

Attached to
Preclinical Medications Discovery and Abuse Liability Testing Federal contract opportunity
Solicitation number
75N95021R00048
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

About this file

This document provides details for a solicitation seeking preclinical medications discovery and abuse liability testing services. The National Institute on Drug Abuse is soliciting proposals for evaluation of potential pharmacotherapies for substance use disorders and new drugs of abuse using rodent and primate models. Testing will include assessment of receptor activity, dependence and withdrawal evaluation, and operant behavioral models. The contractor must have in-house capability for pharmacology studies and DEA registration for scheduled substances. Proposals are due by November 22, 2021 and the contract will have a one-year base period and four one-year options, along with additional optional labor hours and costs. The contractor will provide blinded evaluation of compounds and detailed reports to the Addiction Treatment Discovery Program. This represents a competitive renewal of an existing contract to support the program's medication development efforts.

View the file

Other files for this federal contract opportunity

Other files attached to Preclinical Medications Discovery and Abuse Liability Testing, newest first.
File Type Posted
22-8959 RFP 75N95021R00048.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

NSN 7540 - 01 - 152 � 8070 STANDARD FORM 30 (REV. 10-83)

PREVIOUS EDITION UNUSABLE Prescribed by GSA

FAR (48CFR) 53.243

OMB No. 0990-0115

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES

2. AMENDMENT/MODIFICATION NO. 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQ. NO. 5. PROJECT NO. (If applicable)

01 See Block 16C. N01DA-22-8959

6. ISSUED BY CODE NIDA-EXEC 7. ADMINISTERED BY (If other than Item 6) CODE NIDA National Institute on Drug Abuse, NIH Office of Acquisitions c/o 3WFN MSC 6012 301 N Stonestreet Ave Bethesda, MD 20892

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

TO ALL OFFERORS

9A. AMENDMENT OF SOLICITATION NO.

75N95021R00048

9B. DATED (SEE ITEM 11)

November 5, 2021

10A. MODIFICATION OF CONTRACT/ORDER NO.

10B. DATED (SEE ITEM 13)

CODE FACILITY CODE

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offer is extended is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing Item 8 and 15, and returning 1 copies of the amendment; (b) acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDG- MENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hours and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT/ORDER NO. IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not, is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

PURPOSE: To answer questions regarding the Request for Proposal (RFP) 75N95021R00048; see page 2 and 3 of this Amendment No. 01.

PROPOSAL DUE DATE: 10:00 a.m. (Eastern time) on November 22, 2021 (UNCHANGED).

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

Tracy Cain, Contracting Officer

15B. CONTRACTOR/OFFEROR 15C. DATE SIGNED 16B. UNITED STATES OF AMERICA 16C. DATE SIGNED

(Signature of person authorized to sign)

BY

(Signature of Contracting Officer)

2021-11-05T12:41:35-0400
Tracy L. Cain -S

File details come from the government source that posted it. Updated .